BGB-102
BGB-102 is a potent multi-kinase inhibitor against EGFR, HER2, and HER4 with IC50s of 9.6 nM, 18 nM and 40.3 nM, respectively.
Product Specifications
CAS Number
[807640-87-5]
Product Name Alternative
JNJ-26483327
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BGB-102.html
Purity
99.52
Solubility
DMSO : 4.4 mg/mL (ultrasonic) |THF : ≥ 7.27 mg/mL
Smiles
CN1CCCCCOC(C(OC)=C2)=CC3=C2N=CN/C3=N\C4=CC(Br)=CC=C4C1
Molecular Formula
C22H25BrN4O2
Molecular Weight
457.36
References & Citations
[1]Gijsen M, et al. HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol. 2010 Dec 21;8 (12) :e1000563.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
EGFR/ErbB1/HER1; ErbB2/HER2; ErbB4/HER4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A0855-39E 100 µg
Activation Transcription Factor 1 (Activating Transcription Factor 1, ATF 1, ATF1, ATF-1, ATF1 EWS Fusion Gene, ATF1 FUS Fusion Gene, Cyclic AMP-dependent Transcription Factor ATF1, Cyclic AMP Dependent Transcription Factor ATF1, cAMP-dependent Transcription Factor 1, EWS ATF1, FUS ATF1, RNA Binding Protein Activating Transcription Factor 1 Fusion Protein, TREB36, TREB36 Protein) discontinued
Ask
View Details